• Register
  • Login
  • Subscribe
  • Contact Us

Latest Tablets Tenders in Guatemala 2026

GuatemalaTenders brings you the latest and most relevant Tablets tenders in Guatemala, sourced directly from reliable government portals, purchaser websites, and leading procurement publications. Whether you're a supplier, contractor, or manufacturer, we ensure you stay informed about ongoing bidding opportunities without missing a beat.

Our platform is regularly updated with tenders related to Tablets and other keywords tenders. Each listing includes key details such as tender reference numbers, submission deadlines, and purchaser information helping you make informed bidding decisions quickly and confidently.

By subscribing to GuatemalaTenders, users gain unlimited access to public procurement notices related to Tablets. Our tools also offer category-based filtering, email alerts, and quick tender downloads, making your bidding process faster and more efficient. Stay ahead of the competition and grow your business by exploring verified tenders from both government and private entities across Guatemala.

Simvastatine, Tablet 20 Mg.

GTT Ref No.:  124030755

Deadline:  07 Aug 2025

Indapamide, Extended-release Tablet 1.5 Mg.

GTT Ref No.:  124030654

Deadline:  07 Aug 2025

Dutasteride Tamsulosin, Extended-release Tablet 0.5mg/0.4mg.

GTT Ref No.:  124030652

Deadline:  07 Aug 2025

Indapamide, Extended-release Tablet 1.5 Mg.

GTT Ref No.:  124030550

Deadline:  07 Aug 2025

Dutasteride Tamsulosin, Extended-release Tablet 0.5mg/0.4mg.

GTT Ref No.:  124030529

Deadline:  07 Aug 2025

Simvastatine, Tablet 20 Mg

GTT Ref No.:  124028213

Deadline:  07 Aug 2025

Metformin, Extended-release Tablet 1000 Mg

GTT Ref No.:  124027930

Deadline:  07 Aug 2025

Tolvaptan, 30 Mg Tablets, Trademark "Tolkistan"

GTT Ref No.:  124027779

Deadline:  07 Aug 2025

Siaf 3820/2025, Code 354 - Metformin, Extended-release Tablet 1000 Mg

GTT Ref No.:  124027629

Deadline:  07 Aug 2025

Simvastatine, Tablet 20 Mg.

GTT Ref No.:  124027627

Deadline:  07 Aug 2025

  Chat with us